Birdwatch Note Rating
2024-03-16 21:24:59 UTC - NOT_HELPFUL
Rated by Participant: 8B304C6001B4C81A5AE136053ABAD113D402A79267A355979B13D01E0E1D0BB5
Participant Details
Original Note:
No, the Ebola clinical trial involving the COVID-19 drug Remdesivir did not show Remdesivir had a 53% mortality rate. This is a false interpretation of the study. The study showed that Ebola infection had a 53% mortality rate. Ebola can have up to a 90% mortality rate https://www.nejm.org/doi/full/10.1056/nejmoa1910993 https://www.paho.org/en/topics/ebola-virus-disease
All Note Details